ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,916.98
0.40%
Dow Jones
43,268.94
-0.28%
US Dollar vs MXN
20.13525
0.11%
Brent Oil
73.235
0.21%
Bitcoin
93,265.27
1.00%
Pepperstone
Advertisement
Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Europa
  5. EU

  6. Cellectis Nom Eo 05 (ALCLS) Cotización

Cellectis Nom Eo 05

Cellectis Nom Eo 05 (ALCLS)

EU
1.794
0.014
( 0.79% )
Actualizado: 02:10:45
Delayed by 15 minutes

Su centro para precios en tiempo real, ideas y debates en vivo

Premium

Estadísticas y detalles clave

Último Precio
1.794
Postura de Compra
1.782
Postura de Venta
1.794
Volume Operado de la Acción
155
1.79 Rango del Día 1.794
1.634 Rango de 52 semanas 3.44
Capitalización de Mercado [m]
82.3M
Precio Anterior
1.78
Precio de Apertura
1.79
Hora
48
@
1.794
Última hora de negociación
02:04:17
Volumen financiero
-
Precio Promedio Ponderado
-
Volumen promedio (3 m)
36,829
Acciones en circulación
45,874,895
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
-0.81
Beneficio por acción (BPA)
-2.2
turnover
9.24M
Beneficio neto
-101.06M

Acerca de Cellectis Nom Eo 05

Sector
Pharmaceutical Preparations
Industria
Pharmaceutical Preparations
Sitio web
www.cellectis.com
Sede
Paris, Paris, Fra
Fundado
-
Cellectis Nom Eo 05 is listed in the Pharmaceutical Preparations sector of the Euronext with ticker ALCLS. The last closing price for Cellectis Nom Eo 05 was 1.78 €. Over the last year, Cellectis Nom Eo 05 shares have traded in a share price range of 1.634 € to 3.44 €.

Cellectis Nom Eo 05 currently has 45,874,895 shares in issue. The market capitalisation of Cellectis Nom Eo 05 is 81.66 € million. Cellectis Nom Eo 05 has a price to earnings ratio (PE ratio) of -0.81.

ALCLS Últimas noticias

Más noticias

Monthly information on share capital and company voting rights

Monthly information on share capital and company voting rights (Article 223-16 of General Regulation of the French financial markets authority)PARIS, Nov. 06, 2024 (GLOBE NEWSWIRE) -- Listing...

06 Noviembre 2024
UK Regulatory

Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social

Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social (Article 223-16 du Règlement Général de l’Autorité des Marchés Financiers)PARIS, 06 nov...

06 Noviembre 2024
UK Regulatory

Cellectis présente de multiples stratégies pour améliorer l'efficacité des cellules CAR T dans les tumeurs solides à la réunion annuelle de la SITC

Cellectis présente de multiples stratégies pour améliorer l'efficacité des cellules CAR T dans les tumeurs solides à la réunion annuelle de la SITC NEW YORK, 05 nov. 2024 (GLOBE NEWSWIRE...

05 Noviembre 2024
UK Regulatory

Cellectis Presents Multiple Strategies to Enhance CAR T-cell Efficacy in Solid Tumors at the SITC Annual Meeting

NEW YORK, Nov. 05, 2024 (GLOBE NEWSWIRE) --  Cellectis (the “Company”) (Euronext Growth: ALCLS - NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform...

05 Noviembre 2024
GlobeNewswire Inc.

Cellectis Presents Multiple Strategies to Enhance CAR T-cell Efficacy in Solid Tumors at the SITC Annual Meeting

Cellectis Presents Multiple Strategies to Enhance CAR T-cell Efficacy in Solid Tumors at the SITC Annual Meeting NEW YORK, Nov. 05, 2024 (GLOBE NEWSWIRE) --  Cellectis (the “Company”) (Euronext...

05 Noviembre 2024
UK Regulatory

Cellectis présente ses résultats financiers du troisième trimestre 2024 et une mise à jour de ses activités

Cellectis présente ses résultats financiers du troisième trimestre 2024 et une mise à jour de ses activités UCART22 et UCART20x22 : recrutement de patients en cours, un ensemble de données de la...

04 Noviembre 2024
UK Regulatory

Cellectis Provides Business Updates and Financial Results for Third Quarter 2024

Cellectis Provides Business Updates and Financial Results for Third Quarter 2024 UCART22 and UCART20x22: enrollment ongoing, Phase 1 dataset and late-stage development strategy to be presented in...

04 Noviembre 2024
UK Regulatory

Cellectis Provides Business Updates and Financial Results for Third Quarter 2024

UCART22 and UCART20x22: enrollment ongoing, Phase 1 dataset and late-stage development strategy to be presented in 2025AstraZeneca partnership: R&D activities are ongoing on three programs –...

04 Noviembre 2024
GlobeNewswire Inc.

Cellectis publiera ses résultats financiers du troisième trimestre 2024 le 4 novembre 2024

Cellectis publiera ses résultats financiers du troisième trimestre 2024 le 4 novembre 2024 NEW YORK, 30 oct. 2024 (GLOBE NEWSWIRE) -- Cellectis (Euronext Growth: ALCLS - Nasdaq: CLLS), société...

30 Octubre 2024
UK Regulatory

Cellectis to Report Third Quarter 2024 Financial Results on November 4, 2024

NEW YORK, Oct. 30, 2024 (GLOBE NEWSWIRE) --  Cellectis (the “Company”) (Euronext Growth: ALCLS- NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform...

30 Octubre 2024
GlobeNewswire Inc.
Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
10.021.12739571591.7741.841.702385381.77435463DE
40.0181.013513513511.7761.871.662404681.73691218DE
12-0.316-14.97630331752.112.1351.662368291.86295206DE
26-0.936-34.28571428572.732.731.634556201.95715184DE
52-0.836-31.78707224332.633.441.634979032.47367369DE
156-6.066-77.17557251917.868.4150.8881605573.00152467DE
260-10.166-8511.9628.150.8881406526.68223598DE

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
ALNEVNeovacs
0.0003 €
(50.00%)
5.84M
ALAGOEPango SA
0.1332 €
(25.66%)
1.95M
HYLHyloris Pharmaceuticals SA
4.66 €
(16.50%)
9.78k
ALVIOValerio Therapeutics
0.0813 €
(12.92%)
32.25k
ALAMAAMA Corporation PLC
0.19 €
(11.76%)
19.98k
EMGDSEuromedis DS
0.0002 €
(-98.28%)
33
ALSAFSAFE
0.0711 €
(-16.35%)
25.32k
ELIORElior Group
3.498 €
(-15.01%)
1.26M
ATODSAtos SE
0.0043 €
(-12.24%)
1.62M
ALVERVergnet
0.004 €
(-9.09%)
123k
ALNEVNeovacs
0.0003 €
(50.00%)
5.84M
BCPBanco Comercial Portugues SA
0.441 €
(0.27%)
2.42M
ALCYBCybergun
0.0002 €
(0.00%)
2.37M
ALAGOEPango SA
0.1332 €
(25.66%)
1.95M
ALTDTonner Drones
0.009 €
(2.27%)
1.92M

Discusión

Ver feed completo
lovethatgreen lovethatgreen 3 minutos hace
MONI

We shall see something spectacular develop here soon .

We partner with the world’s leading experts, blending their knowledge with practical strategies to deliver impactful results and drive profitability in record time.
Defense Solutions

A ke
MONI
Dingbatt Dingbatt 4 minutos hace
Fish
Any word on how long it’s going to take you to land the marlin
Truth_is_a_tool Truth_is_a_tool 4 minutos hace
Well it’s a new prospectus that potentially new investors will read. You’d think he’d take the time to ensure it’s updated and accurate. I honestly just don’t know; I’m just keeping my feet on the ground. My hope is you’re right but I wouldn’t be surprised if we learn they need a little more time to
KBLB
jxyzobrien jxyzobrien 11 minutos hace
at this time
the market does not care about new policies
it is still operating on the same things it has been all year
i really thought uncertainty would be an issue
its got blinders on

when it sells hard 3 days in a row then new policies are an issue
jeunke22 jeunke22 13 minutos hace
Just an after thought. The marketing prowess and the market position of a Tier 1 transceiver company who decides to opt for Lightwave is of course also very decisive for Lightwave’s ultimate success. If Broadcom would opt for Lightwave that would be different than e.g. Open Light,
LWLG
luvwetscent luvwetscent 15 minutos hace
Technical analysis...mumbo jumbo chicken gumbo...another research company like Zacks to begin coverage would be the ticket.
ELTP
weedtrader420 weedtrader420 26 minutos hace
Everybody filled up XRP✊😎🚀📈 B.I.G.NOTORIOUS THUGS
XRPUSD
Seminole Red Seminole Red 28 minutos hace
lolol
lovethatgreen lovethatgreen 36 minutos hace
Gibiru number 8

Searchrockit coming in hot soon
MONI
weedtrader420 weedtrader420 37 minutos hace
SUKU BITCOIN 🏎️🏎️ LET THE TIMES ROLL
BTCUSD
dalesio_98 dalesio_98 38 minutos hace
New money98,

You indicated you would provide the R-2 exhibits for review, I await the same.

Good luck to All!
GVInvestments GVInvestments 39 minutos hace
Ok that's good news. Do you know if he is a shareholder in Fannie ?
FNMA
GVInvestments GVInvestments 42 minutos hace
If going to give Buffet some of my shares just so that we can say that he is a shareholder.I'll look to see how I can transfer 2 shares to him tomorrow.
FNMA
weedtrader420 weedtrader420 42 minutos hace
XRP 😵DREAM WEAVER $10 TARGET
XRPUSD
Seminole Red Seminole Red 43 minutos hace
Linda will clean house, she knows how to deal with tough people
Seminole Red Seminole Red 45 minutos hace
Personally , I think OZ is a quack but what do I know.....
Golden Cross Golden Cross 48 minutos hace
$ILLR Cheapest of all the Social Media Stocks. With Triller 5.0 now launching and the #TikTok ban to begin in Jan. 2025 this is truly the ground floor here! Very Undervalued here given the current market cap.

https://investorshub.advfn.com/uimage/uploads/2024/11/20/hqnorCopy_of_Red_an
ILLR
Seminole Red Seminole Red 49 minutos hace
on Jan. 3rd Thune will be installed and McConnell gone.....thaats when the fun starts, Before the Inauguration
Golden Cross Golden Cross 49 minutos hace
$ILLR Cheapest of all the Social Media Stocks. With Triller 5.0 now launching and the TikTok ban to begin in Jan. 2025 this is truly the ground floor here! Very Undervalued here given the current market cap.

https://investorshub.advfn.com/uimage/uploads/2024/11/20/hqnorCopy_of_Red_and
ILLR
weedtrader420 weedtrader420 50 minutos hace
XRP ✊😎📈TIME IN A BOTTLE
XRPUSD
weedtrader420 weedtrader420 53 minutos hace
This is getting exciting✊😎☝️🚀 XRP Rocky Mountain High $5 SUKU SUKU BONK🤑🤑🤑🤑🤑🤑📈
XRPUSD
MusicExec MusicExec 54 minutos hace
One full month has now nearly passed since you were approinted as the IR and we are still waiting for answers.

We have seen the SONG share price continue plummeting a further 80% to 0.0175 from 0.1 when you were appointed just a month ago continuing the downward trend that led to the
SONG
weedtrader420 weedtrader420 57 minutos hace
BITCOIN SUKU BONK Rocky Mountain High $107 TARGET TODAY
BTCUSD
12ka 12ka 1 hora hace
500M diluted in a week old notes from crooked CEO hooking up his convertable buddies...has to stop
RDAR

Su Consulta Reciente

EU
ALCLS
Cellectis Nom Eo 05
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados